Why would studies on furry rodents concern us as clinicians?

Scandinavian Journal of Pain

Volumn 1, Issue 2, 2010, Pages 89-90

  Kontinen, Vesa K ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; VENLAFAXINE;

ALLODYNIA; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CLINICAL PRACTICE; CLINICAL STUDY; DIABETIC NEUROPATHY; DISEASE MODEL; DRUG BINDING; DRUG EFFECT; DRUG TRANSPORT; HUMAN; HYPERALGESIA; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RODENT; SPRAGUE DAWLEY RAT; SYNAPSE;

EID: 77649287371     PISSN: 18778860     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjpain.2010.01.003     Document Type: Note

References (21)

1. Folkesson A., Hartvig Honoré P., and Bjerrum O.J. Co-adminstyered gabapentin and venlafaxin in verve injured rats: effect on mechanical hypersensitivity, motor function and pharmakokinetics. Scand J Pain 1 (2010) 91-97
2. Rode F., Broløs T., Blackburn-Munro G., and Bjerrum O.J. Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain. Psychopharmacology (Berl) 187 (2006) 364-375
3. Dworkin R.H., O'Connor A.B., Backonja M., Farrar J.T., Finnerup N.B., Jensen T.S., Kalso E.A., Loeser J.D., Miaskowski C., Nurmikko T.J., Portenoy R.K., Rice A.S.C., Stacey B.R., Treede R.-D., Turk D.C., and Wallace M.S. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132 (2007) 237-251
4. Simpson D.A. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 3 (2001) 53-62
5. Ohtsuki S., and Terasaki T. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm Res 24 (2007) 1745-1758
6. Urquhart B.L., and Kim R.B. Blood-brain barrier transporters and response to CNS-active drugs. Eur J Clin Pharmacol 65 (2009) 1063-1070
7. Taylor C.P. Mechanisms of analgesia by gabapentin and pregabalin-calcium channel alpha2-delta [Cavalpha2-delta] ligands. Pain 142 (2009) 13-16
8. Tanabe M., Takasu K., Kasuya N., Shimizu S., Honda M., and Ono H. Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse. Br J Pharmacol 144 (2005) 703-714
9. Hayashida K.-I., DeGoes S., Curry R., and Eisenach J.C. Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. Anesthesiology 106 (2007) 557-562
10. Takasu K., Kinoshita Y., Ono H., and Tanabe M. Protein kinase A-dependence of the supraspinally mediated analgesic effects of gabapentin on thermal and mechanical hypersensitivity. J Pharmacol Sci 110 (2009) 223-226
11. Takeuchi Y., Takasu K., Honda M., Ono H., and Tanabe M. Neurochemical evidence that supraspinally administered gabapentin activates the descending noradrenergic system after peripheral nerve injury. Eur J Pharmacol 556 (2007) 69-74
12. Tanabe M., Takasu K., Takeuchi Y., and Ono H. Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury. J Neurosci Res 86 (2008) 3258-3264
13. Tallarida R.J. An overview of drug combination analysis with isobolograms. J Pharmacol Exp Ther 319 (2006) 1-7
14. Esser M.J., and Sawynok J. Acute amitriptyline in a rat model of neuropathic pain: differential symptom and route effects. Pain 80 (1999) 643-653
15. Esser M.J., Chase T., Allen G.V., and Sawynok J. Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions. Eur J Pharmacol 430 (2001) 211-218
16. Eroglu C., Allen N.J., Susman M.W., O'Rourke N.A., Park C.Y., Ozkan E., Chakraborty C., Mulinyawe S.B., Annis D.S., Huberman A.D., Green E.M., Lawler J., Dolmetsch R., Garcia K.C., Smith S.J., Luo Z.D., Rosenthal A., Mosher D.F., and Barres B.A. Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 139 (2009) 380-392
17. Kontinen V.K., and Meert T.F. Predicitive validity of neuropathic pain models in pharmacological studies with behavioural outcome in the rat: a systematic review. In: Dostrovsky J.O., Carr D.B., and Kolzenburg M. (Eds). Proceedings of the 10th world congress on pain IASP press seattle (2003) 489-498
18. Moore R., Derry S., McQuay H., Straube S., Aldington D., Wiffen P., Bell R., Kalso E., Rowbotham M., and for the ACTINPAIN writing group of the IASP Special Interest Group (SIG) on Systematic Reviews in Pain Relief. Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences. Pain (2009) 10.1016/j.pain.2009.1008.1007
19. Decosterd I., and Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87 (2000) 149-158
20. Shields S.D., Eckert W.A., and Basbaum A.I. Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysis. J Pain 4 (2003) 465-470
21. Rice A., Cimino-Brown D., Eisenach J., Kontinen V., Lacroix-Fralish M., Machin I., Mogil J., and Stohr T. Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards. Pain 139 (2008) 243-247